Board MeetingMay 8, 2026, 04:32 PM
MiNK Therapeutics to Report Q1 2026 Results on May 15
AI Summary
MiNK Therapeutics announced it will report its first quarter 2026 financial results before market open on Friday, May 15, 2026. The company will host a conference call and webcast at 8:30 AM ET to discuss the results and provide a corporate update. The update will cover recent progress in its iNKT cell therapy platform, including the advancement of agenT-797, scientific presentations, and its collaboration with C-Further for pediatric cancers.
Key Highlights
- MiNK Therapeutics to report Q1 2026 financial results on May 15, 2026.
- Conference call and webcast scheduled for May 15, 2026, at 8:30 AM ET.
- Update to cover progress on iNKT cell therapy platform.
- Advancement of lead therapy, agenT-797, for cancer and immune diseases.
- Collaboration with C-Further for PRAME-targeted iNKT cell therapy.
Price Impact
More from INKT